1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two. Issue 1 (November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina; Bajaj, Anshika; Archer, Jacob; Reeves, Rebecca; Ngo, Lisa; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fuseri, Nicola... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients. (9th November 2020) Authors: El-Khoueiry, Anthony; Thomas, Jacob; Olszanski, Anthony; Azad, Nilofer; Bender, Lewis; Walters, Ian; Whalen, Giles; Hanna, Diana; Ingham, Matthew; Siu, Lilian Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 411 Novel intratumoral agent, INT230–6 induces cancer cell death, increases tumor infiltrates and results in durable benefit alone or in combination with pembrolizumab in refractory patients. (9th November 2020) Authors: El-Khoueiry, Anthony; Thomas, Jacob; Olszanski, Anthony; Azad, Nilofer; Bender, Lewis; Walters, Ian; Whalen, Giles; Hanna, Diana; Ingham, Matthew; Siu, Lilian Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. INT230-6 shows strong synergy with anti-PD-1 and can induce high complete response rates with T cell memory response in a colon cancer mouse model. Issue 2 (December 2015) Authors: Bloom, Anja; Bender, Lewis; Terabe, Masaki; Berzofsky, Jay; Walters, Ian Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗